By: Philia Pak Experea Healthcare Blog Editor Every story – whether it be a story of loss or gain, deserves to be shared. This is the story of the Berry Children. I first came across the Berry Children’s story when I noticed a flood of profile picture changes take over my Facebook newsfeed. Almost instantaneously, people [...]
According to a report from the Chicago Tribune, a stem cell trial’s cancellation disappoints paraplegic patient and a Northwestern researcher.
Ryan Neslund found out he never would be able to walk again after a motorcross accident in April 2011. Neslund, who now resides in Arizona, joined a clinical trial of an embryonic stem cell therapy within weeks of his accident. That trial was ended, though neslund will continue to be monitored.
Dr. Richard Fessler, a professor of neurosurgery at Northwestern University, performed one of the first surgeries of it’s kind on Neslund using controversial stem cell therapy. However, sever months later, after a total of four patients had received the transplants, Fessler opened an email from his office informing him that the trial was finished.
” Geron Corp., the California-based company financing the study, had decided to shift focus to cancer drugs, and with that move, another foray into stem cell therapies had come to a jarring end,” explains reporter Cynthia Dizikes, Chicago Tribune reporter.
To learn more, click here.
Congratulations to our Director of Sales, Dean Maccabe who has just been featured in the latest issue of Sports N Spokes Magazine! We are so proud of you and excited for others to know the incredible story and life journey you have been through since your spinal cord injury. Dean has been an integral part [...]
